These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30641248)

  • 1. Could high lithium levels in tobacco contribute to reduced risk of Parkinson's disease in smokers?
    Guttuso T; Russak E; De Blanco MT; Ramanathan M
    J Neurol Sci; 2019 Feb; 397():179-180. PubMed ID: 30641248
    [No Abstract]   [Full Text] [Related]  

  • 2. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
    Guttuso T
    Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addiction to nicotine is due to high intrinsic levels of dopamine.
    Paulson GW
    Med Hypotheses; 1992 Jul; 38(3):206-7. PubMed ID: 1513274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and Parkinson's disease.
    Baron JA
    Neurology; 1986 Nov; 36(11):1490-6. PubMed ID: 3531917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies.
    Hernán MA; Zhang SM; Rueda-deCastro AM; Colditz GA; Speizer FE; Ascherio A
    Ann Neurol; 2001 Dec; 50(6):780-6. PubMed ID: 11761476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking and Parkinson's disease--a new perspective.
    Shahi GS; Moochhala SM
    Rev Environ Health; 1991; 9(3):123-36. PubMed ID: 1792386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smoking, nicotine and Parkinson's disease.
    Quik M
    Trends Neurosci; 2004 Sep; 27(9):561-8. PubMed ID: 15331239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced nicotine content cigarettes in smokers of low socioeconomic status: study protocol for a randomized control trial.
    Krebs NM; Allen SI; Veldheer S; Martinez DJ; Horn K; Livelsberger C; Modesto J; Kuprewicz R; Wilhelm A; Hrabovsky S; Kazi A; Fazzi A; Liao J; Zhu J; Wasserman E; Reilly SM; Reinhart L; Trushin N; Moyer RE; Bascom R; Foulds J; Richie JP; Muscat JE
    Trials; 2017 Jul; 18(1):300. PubMed ID: 28673312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moist smokeless tobacco (Snus) use and risk of Parkinson's disease.
    Yang F; Pedersen NL; Ye W; Liu Z; Norberg M; Forsgren L; Trolle Lagerros Y; Bellocco R; Alfredsson L; Knutsson A; Jansson JH; Wennberg P; Galanti MR; Lager ACJ; Araghi M; Lundberg M; Magnusson C; Wirdefeldt K
    Int J Epidemiol; 2017 Jun; 46(3):872-880. PubMed ID: 27940486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
    D'Ruiz CD; Graff DW; Yan XS
    BMC Public Health; 2015 Sep; 15():991. PubMed ID: 26424091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and Parkinson's disease.
    Godwin-Austen RB; Lee PN; Marmot MG; Stern GM
    J Neurol Neurosurg Psychiatry; 1982 Jul; 45(7):577-81. PubMed ID: 7119826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cessation among smokers of "light" cigarettes: results from the 2000 national health interview survey.
    Tindle HA; Rigotti NA; Davis RB; Barbeau EM; Kawachi I; Shiffman S
    Am J Public Health; 2006 Aug; 96(8):1498-504. PubMed ID: 16809583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of cigarette consumption and smoking machine yields of tar and nicotine on the nicotine uptake and oral mucosal lesions in smokers.
    Andersson G; Vala EK; Curvall M
    J Oral Pathol Med; 1997 Mar; 26(3):117-23. PubMed ID: 9083935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links?
    Castagnoli K; Murugesan T
    Neurotoxicology; 2004 Jan; 25(1-2):279-91. PubMed ID: 14697903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced nicotine cigarettes: smoking behavior and biomarkers of exposure among smokers not intending to quit.
    Hammond D; O'Connor RJ
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):2032-40. PubMed ID: 25150282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tobacco--once a medicinal plant. Does it contain substances with medicinal properties?].
    Budzianowski J
    Przegl Lek; 2013; 70(10):865-8. PubMed ID: 24501813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease and smoking: an integral part of PD's etiological study.
    Dong JQ; Zhang ZX; Zhang KL
    Biomed Environ Sci; 2003 Jun; 16(2):173-9. PubMed ID: 12964791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High lithium levels in tobacco, incidences of Parkinson's disease and melanoma: Mechanism of the association.
    Kawada T
    Med Hypotheses; 2020 Oct; 143():110045. PubMed ID: 32615500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.